Cargando…
Responder analyses and the assessment of a clinically relevant treatment effect
Ideally, a clinical trial should be able to demonstrate not only a statistically significant improvement in the primary efficacy endpoint, but also that the magnitude of the effect is clinically relevant. One proposed approach to address this question is a responder analysis, in which a continuous p...
| Autores principales: | , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2007
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2164942/ https://www.ncbi.nlm.nih.gov/pubmed/17961249 http://dx.doi.org/10.1186/1745-6215-8-31 |